TMBIM6 overexpression enhanced proliferation, invasion, migration, GSH/GPX4 levels, and ferroptosis resistance while suppressing MDA, Fe2+, and lipid ROS in bladder cancer cells, effects reversed by Erastin. The gene discussed is TMBIM6; the disease is urinary bladder cancer.